Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study.

Autor:	Lisdahl KM; University of Wisconsin, Milwaukee, WI, United States; Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: medinak@uwm.edu., Tapert S; University of California, San Diego, CA, United States., Sher KJ; University of Missouri, Columbia, MO, United States., Gonzalez R; Florida International University, Miami, FL, United States., Nixon SJ; University of Florida, Gainesville, FL, United States., Feldstein Ewing SW; Oregon Health & Science University, Portland, OR, United States., Conway KP; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Wallace A; University of Wisconsin, Milwaukee, WI, United States., Sullivan R; University of Wisconsin, Milwaukee, WI, United States., Hatcher K; University of Wisconsin, Milwaukee, WI, United States., Kaiver C; University of Wisconsin, Milwaukee, WI, United States., Thompson W; University of California, San Diego, CA, United States., Reuter C; University of California, San Diego, CA, United States., Bartsch H; University of California, San Diego, CA, United States., Wade NE; University of California, San Diego, CA, United States., Jacobus J; University of California, San Diego, CA, United States., Albaugh MD; University of Vermont, Burlington, VT, United States., Allgaier N; University of Vermont, Burlington, VT, United States., Anokhin AP; Washington University, St. Louis, MO, United States., Bagot K; University of California, San Diego, CA, United States; Icahn School of Medicine at Mount Sinai, United States., Baker FC; SRI International, Menlo Park, CA, United States., Banich MT; University of Colorado Boulder, CO, United States., Barch DM; Washington University, St. Louis, MO, United States., Baskin-Sommers A; Yale University, New Haven, CT, United States., Breslin FJ; Laureate Institute for Brain Research, Tulsa, OK, United States., Brown SA; University of California, San Diego, CA, United States., Calhoun V; Georgia State University, Atlanta, GA, United States., Casey BJ; Yale University, New Haven, CT, United States., Chaarani B; University of Vermont, Burlington, VT, United States., Chang L; University of Maryland School of Medicine, Baltimore, MD, United States., Clark DB; University of Pittsburgh, Pittsburgh, PA, United States., Cloak C; University of Maryland School of Medicine, Baltimore, MD, United States., Constable RT; Yale University, New Haven, CT, United States., Cottler LB; University of Florida, Gainesville, FL, United States., Dagher RK; National Institute of Minority Health and Health Disparities, Bethesda, MD, United States., Dapretto M; University of California, Los Angeles, CA, United States., Dick A; Florida International University, Miami, FL, United States., Do EK; Virginia Commonwealth University, Richmond, VA, United States., Dosenbach NUF; Washington University, St. Louis, MO, United States., Dowling GJ; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Fair DA; University of Minnesota, Minneapolis, MN, United States., Florsheim P; University of Wisconsin, Milwaukee, WI, United States., Foxe JJ; University of Rochester, Rochester, NY, United States., Freedman EG; University of Rochester, Rochester, NY, United States., Friedman NP; University of Colorado Boulder, CO, United States., Garavan HP; University of Vermont, Burlington, VT, United States., Gee DG; Yale University, New Haven, CT, United States., Glantz MD; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Glaser P; Washington University, St. Louis, MO, United States., Gonzalez MR; Children's Hospital Los Angeles, Los Angeles, CA, United States., Gray KM; Medical University of South Carolina, Charleston, SC, United States., Grant S; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Haist F; University of California, San Diego, CA, United States., Hawes S; Florida International University, Miami, FL, United States., Heeringa SG; University of Michigan, Ann Arbor, MI, United States., Hermosillo R; Oregon Health & Science University, Portland, OR, United States., Herting MM; University of Southern California, Los Angeles, CA, United States., Hettema JM; Virginia Commonwealth University, Richmond, VA, United States., Hewitt JK; University of Colorado Boulder, CO, United States., Heyser C; University of California, San Diego, CA, United States., Hoffman EA; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Howlett KD; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Huber RS; University of Utah, Salt Lake City, UT, United States., Huestis MA; University of California, San Diego, CA, United States; Thomas Jefferson University, Philadelphia, PA, United States., Hyde LW; University of Michigan, Ann Arbor, MI, United States., Iacono WG; University of Minnesota, Minneapolis, MN, United States., Isaiah A; University of Maryland School of Medicine, Baltimore, MD, United States., Ivanova MY; University of Vermont, Burlington, VT, United States., James RS; American Psychistric Association, United States., Jernigan TL; University of California, San Diego, CA, United States., Karcher NR; Washington University, St. Louis, MO, United States., Kuperman JM; University of California, San Diego, CA, United States., Laird AR; Florida International University, Miami, FL, United States., Larson CL; University of Wisconsin, Milwaukee, WI, United States., LeBlanc KH; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Lopez MF; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Luciana M; University of Minnesota, Minneapolis, MN, United States., Luna B; University of Pittsburgh, Pittsburgh, PA, United States., Maes HH; Virginia Commonwealth University, Richmond, VA, United States., Marshall AT; Children's Hospital Los Angeles, Los Angeles, CA, United States., Mason MJ; University of Tennessee, Knoxville, TN, United States., McGlade E; University of Utah, Salt Lake City, UT, United States., Morris AS; Laureate Institute for Brain Research, Tulsa, OK, United States; Oklahoma State University, Stillwater, OK, United States., Mulford C; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Nagel BJ; Oregon Health & Science University, Portland, OR, United States., Neigh G; Virginia Commonwealth University, Richmond, VA, United States., Palmer CE; University of California, San Diego, CA, United States., Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, United States., Pecheva D; University of California, San Diego, CA, United States., Prouty D; SRI International, Menlo Park, CA, United States., Potter A; University of Vermont, Burlington, VT, United States., Puttler LI; University of Michigan, Ann Arbor, MI, United States., Rajapakse N; National Institute of Minority Health and Health Disparities, Bethesda, MD, United States., Ross JM; University of Colorado Anschutz Medical Campus, Aurora, CO, United States., Sanchez M; Florida International University, Miami, FL, United States., Schirda C; University of Pittsburgh, Pittsburgh, PA, United States., Schulenberg J; University of Michigan, Ann Arbor, MI, United States., Sheth C; University of Utah, Salt Lake City, UT, United States., Shilling PD; University of California, San Diego, CA, United States., Sowell ER; Children's Hospital Los Angeles, Los Angeles, CA, United States., Speer N; University of Colorado Boulder, CO, United States., Squeglia L; Medical University of South Carolina, Charleston, SC, United States., Sripada C; University of Michigan, Ann Arbor, MI, United States., Steinberg J; Virginia Commonwealth University, Richmond, VA, United States., Sutherland MT; Florida International University, Miami, FL, United States., Tomko R; Medical University of South Carolina, Charleston, SC, United States., Uban K; University of California, Irvine, CA, United States., Vrieze S; University of Minnesota, Minneapolis, MN, United States., Weiss SRB; National Institute on Drug Abuse, NIH, Bethesda, MD, United States., Wing D; University of California, San Diego, CA, United States., Yurgelun-Todd DA; University of Utah, Salt Lake City, UT, United States., Zucker RA; University of Michigan, Ann Arbor, MI, United States., Heitzeg MM; University of Michigan, Ann Arbor, MI, United States.
Jazyk:	angličtina
Zdroj:	Drug and alcohol dependence [Drug Alcohol Depend] 2021 Oct 01; Vol. 227, pp. 108946. Date of Electronic Publication: 2021 Jul 29.
DOI:	10.1016/j.drugalcdep.2021.108946
Abstrakt:	Background: The Adolescent Brain Cognitive Development ™ Study (ABCD Study®) is an open-science, multi-site, prospective, longitudinal study following over 11,800 9- and 10-year-old youth into early adulthood. The ABCD Study aims to prospectively examine the impact of substance use (SU) on neurocognitive and health outcomes. Although SU initiation typically occurs during teen years, relatively little is known about patterns of SU in children younger than 12. Methods: This study aims to report the detailed ABCD Study® SU patterns at baseline (n = 11,875) in order to inform the greater scientific community about cohort's early SU. Along with a detailed description of SU, we ran mixed effects regression models to examine the association between early caffeine and alcohol sipping with demographic factors, externalizing symptoms and parental history of alcohol and substance use disorders (AUD/SUD). Primary Results: At baseline, the majority of youth had used caffeine (67.6 %) and 22.5 % reported sipping alcohol (22.5 %). There was little to no reported use of other drug categories (0.2 % full alcohol drink, 0.7 % used nicotine, <0.1 % used any other drug of abuse). Analyses revealed that total caffeine use and early alcohol sipping were associated with demographic variables (p's<.05), externalizing symptoms (caffeine p = 0002; sipping p = .0003), and parental history of AUD (sipping p = .03). Conclusions: ABCD Study participants aged 9-10 years old reported caffeine use and alcohol sipping experimentation, but very rare other SU. Variables linked with early childhood alcohol sipping and caffeine use should be examined as contributing factors in future longitudinal analyses examining escalating trajectories of SU in the ABCD Study cohort. (Copyright © 2021 Elsevier B.V. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect